HLA-B and toxic epidermal necrolysis: An increased risk of SJS/TEN is also predicted due to the presence of heterozygous or homozygous HLA-B*15:02 in 0.4% of the population if treated with phenytoin/fosphenytoin30 or carbamazepine/oxcarbazepine41.